Arkolith/Insider Trading/ETTX/Form 4

Perros Manoussos

President and CEO, DirectorEntasis Therapeutics Holdings Inc. (ETTX) · full profile →Form 4 · filed Jul 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2022Disposed to issuer(D)479K——0
Jul 7, 2022Tender(U)56K$2.20$123K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2022Other(J)145K—$00
Jul 11, 2022Other(J)326K—$00
Jul 11, 2022Other(J)70K—$00
Jul 11, 2022Other(J)183K—$00

Transaction Codes

D
Disposition to the issuer
U
See SEC Form 4 code table
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-078800) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML